Service Providers for Havrix (Hepatitis -A) Double
Havrix (Hepatitis A) Double refers to the administration of the two-dose series of the hepatitis A vaccine, typically given six months apart for long-term protection. The first dose provides initial immunity, while the second dose boosts and extends the protection. This vaccine is recommended for individuals at higher risk, such as travelers to regions with high hepatitis A prevalence, people with chronic liver disease, and those in close contact with infected individuals. Side effects are generally mild, such as soreness at the injection site, fatigue, or low-grade fever. Severe reactions are rare. Completing the full series offers long-lasting protection against hepatitis A.
